home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  January 31, 2023
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[(] [3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 450 active entries

Cambridge Research Biochemicals Ltd

17-18 Belasis Court
United Kingdom

Phone: +44 (0) 1642 567180
Fax: +44 (0) 1642 567181


Cambridge Research Biochemicals (CRB) was established in 1980 and is now located in the North-East of England. Originally formed as a spin out from the MRC-LMB in Cambridge to commercialise the then state of the art Fmoc solid phase synthesis method for making peptides, CRB continues to offer custom peptide synthesis as one of its core businesses.  More than forty years on CRB is the second oldest peptide company in the world and as well as peptides provides custom services in antibody production including polyclonal and monoclonal generation and labelling.

CRB offers technical advice and expertise to develop high quality and high affinity custom antibodies to specific protein regions and motifs using peptides and provides an antigen design service to select optimum peptide candidates. CRB has been providing affinity purified antibodies for immunoblotting and IHC for more than 35 years.

The business has a core manufacturing arm delivering custom made peptides for medical research purposes and supporting drug discovery activities. CRB project manages the production of both Polyclonal and Monoclonal antibodies especially those directed towards peptide antigens and distributes on behalf of specialist providers in the field of Radiochemistry, Fluorescent Dyes & Click chemistry tools, PNA (Peptide Nucleic Acid) synthesis and related reagents.

CRB also offers two catalogues: DISCOVERY Peptides and DISCOVERY antibodies featuring a range of well validated targets, made to the highest standards at CRB's facilities.


Selected Categories:
Product Company   Service Company
- Research
- Research
- General
- Research
- Laboratory
- Research
- Services

Last update of this entry: November 09, 2021

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.